ISPC - Cash Flow Statement - iSpecimen Inc.

Millions

	Dec-2024	Dec-2023	Dec-2022	Dec-2021	Dec-2020	Dec-2019	Dec-2018
OPERATING CASH FLOW
Net Income	(12.5)	(11.1)	(10.2)	(9.0)	(4.7)	(4.7)	(5.3)
Depreciation & Amortization	2.3	2.1	1.2	1.0	0.8	0.6	0.5
Deferred Income Tax	0	0	0	1.1	0.3	(0.6)	0.9
Stock Based Compensation	0.2	0.5	0.7	0.6	92.9 K	0.4	0.1
Other Operating Activities	1.7	0.1	0.2	0.9	0.1	0.6	0.8
Change in Working Capital	0	2.6	2.4	(5.3)	3.0	1.1	0.4
Cash From Operations	(8.3)	(5.8)	(5.8)	(10.7)	(0.3)	(2.7)	(2.7)
INVESTING CASH FLOW
Capital Expenditures	56.5 K	(4.7)	(3.2)	(1.0)	(1.1)	(1.5)	(1.0)
Other Items	2.0	(2.5)	0	0	0	0	0
Cash From Investing Activities	2.0	(7.2)	(3.2)	(1.0)	(1.1)	(1.5)	(1.0)
FINANCING CASH FLOW
Common Stock Repurchased	0	0	0	0	0	0	41
Total Debt Repaid	0	0	(3.5)	1.0	2.0	3.1	2.2
Dividends Paid	0	0	0	0	0	0	0
Other Financing Activities	3.9	70.9 K	78.6 K	(3.7)	0	3.67 K	1.3
Cash From Financing Activities	5.8	70.9 K	(3.4)	38.7	2.0	3.1	3.5
CHANGE IN CASH
Net Change In Cash	(0.5)	(13.0)	(12.4)	27.0	0.6	(1.1)	(0.2)
FREE CASH FLOW
Free Cash Flow	(8.3)	(10.6)	(9.0)	(11.7)	(1.4)	(4.2)	(3.7)

Free